Neurotech International Reports Positive Results In Autism Clinical Trial

Perth-based medical solutions company Neurotech International (Neurotech) recently released positive reports for clinical trials of its Mente Autism device. The device helps to produce positive changes in the brain activity, balance, and behavior of children with autism spectrum disorder (ASD).

The trial compared Mente Autism with a control device over a 12 week period, and demonstrated significant reductions in brain wave frequency bands of interest—typically higher for children with ASD—for those using the device. Additionally, individuals using the device demonstrated improved balance with their eyes open instead of closed, which is the opposite of what is typically . . .